/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Effect of triglycerides on cardiovascular risk in patients with a first vs. recurrent acute coronary syndrome
Event: ESC Congress 2024
Topic: Lipids
Session: Lipids in heart disease
Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome
Event: ESC Congress 2024
Topic: Drug therapy
Session: Lipids in heart disease
The determinant role of high-density lipoprotein cholesterol on the recovery of left ventricle ejection fraction after acute coronary syndromes
Event: ESC Congress 2023
Topic: Lipids
Session: Risk factors and prevention: lipids (4)
HDLc levels have a protective effect for in-hospital mortality in Non-STEMI but not in STEMI patients.
Event: ESC Congress 2023
Topic: Lipids
Session: Risk factors and prevention: lipids (3)
The real-world cost and health resource utilization associated to the CNIC-polypill containing Atorvastatin 20mg in secondary prevention patients: a subanalysis of the NEPTUNO study
Event: ESC Preventive Cardiology 2023
Topic: Public Health and Health Economics, Other
Session: Late-Breaking Science session
We need a generalised approach to improve impact at the population level
Event: ESC Preventive Cardiology 2023
Topic: Secondary Prevention
Session: Managing cardiovascular risk: precision medicine for the individual patient or a better generalised approach at the population level?
Differential prognosis of patients candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Platelets and more
Effect on cholesterol remnants and residual lipid risk with PCSK9 inhibitors: the LIPID-REAL Registry
Event: ESC Congress 2022
Topic: Drug therapy
Session: Lipids - Drug therapy 2
Cholesterol remnants distribution in patients admitted for acute coronary syndrome
Event: ESC Congress 2022
Topic: Lipids
Session: Role of lipids in clinical setting
Predictors of no-reflow in patients with myocardial infarction and ST-segment elevation treated with primary angioplasty
Event: ESC Congress 2022
Topic: Complications
Session: STEMI
